期刊
PRIMARY CARE DIABETES
卷 7, 期 1, 页码 1-10出版社
ELSEVIER SCI LTD
DOI: 10.1016/j.pcd.2012.11.002
关键词
Diabetes mellitus; Depression; Diabetes distress; Screening; Primary care; Cognitive behavioral therapy
资金
- Eli Lilly
- Merck
- MSD
- Novo Nordisk
- Sanofi Aventis
- Takeda
- Bioton
- Servier
- NIHR CLAHRC
- Boehringer-Ingelheim
- Mannkind
- Pfizer
- Astra Zeneca
- Diabetes Research Foundation
- Lifescan
Family physicians are responsible for diagnosing and treating the majority of people with type 2 diabetes mellitus and co-morbid depression. As a result of the impact of co-morbid depression on patient self-care and treatment outcomes, screening for depression in the context of a structured approach to case management and patient follow up is recommended in people with diabetes and cardiovascular disease. This review summarizes the need for improved recognition and treatment of depression in diabetes; and makes expert recommendations with regard to integrating screening tools and therapies into a busy family or general medical practice setting. (C) 2012 Primary Care Diabetes Europe. Published by Elsevier Ltd. All rights reserved.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据